Structure-based drug design of novel urokinase plasminogen activator inhibitors.

被引：0

作者：

Subasinghe, N ^{[1
]}

Hoffman, J ^{[1
]}

Rudolph, J ^{[1
]}

Soll, R ^{[1
]}

Wilson, K ^{[1
]}

Randle, T ^{[1
]}

Green, D ^{[1
]}

Lewandowski, F ^{[1
]}

Zhang, M ^{[1
]}

Bone, R ^{[1
]}

Spurlino, J ^{[1
]}

Deckman, I ^{[1
]}

Manthey, C ^{[1
]}

Zhou, Z ^{[1
]}

Sharp, C ^{[1
]}

Kratz, D ^{[1
]}

Grasberger, B ^{[1
]}

DesJarlais, R ^{[1
]}

Molloy, CJ ^{[1
]}

Illig, C ^{[1
]}

机构：

[1] 3 Dimens Pharmaceut Inc, Exton, PA 19341 USA

来源：

CLINICAL CANCER RESEARCH | 1999年 / 5卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

556

引用

页码：3841S / 3841S

页数：1

共 50 条

[1] Structure-based design, synthesis and SAR of a novel series of thiopheneamidine urokinase plasminogen activator inhibitors
Subasinghe, NL
Illig, C
Hoffman, J
Rudolph, MJ
Wilson, KJ
Soll, R
Randle, T
Green, D
Lewandowski, F
Zhang, M
Bone, R
Spurlino, J
DesJarlais, R
Deckman, I
Molloy, CJ
Manthey, C
Zhou, Z
Sharp, C
Maguire, D
Crysler, C
Grasberger, B
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (11) : 1379 - 1382
[2] Urokinase-type plasminogen activator inhibitors.
Squires, N
McGee, D
Allen, D
Hruzewicz, W
Spencer, J
Sprengeler, P
Katz, B
Luong, C
Mackman, R
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U51 - U51
[3] Structure-based drug design of HIV protease inhibitors.
Navia, MA
Tung, RD
Chaturvedi, PR
Rao, BG
Partaledis, JA
Kim, EE
[J]. FASEB JOURNAL, 1996, 10 (06): : 2436 - 2436
[4] STRUCTURE-BASED DRUG DESIGN OF A NOVEL SERIES OF HUMAN CATHEPSIN D INHIBITORS.
Lee, Angela Y.
Majer, Pavel
Gulnik, Sergei V.
Collins, Jack
Silva, Abelardo M.
Bhat, Narayana T.
Erickson, John W.
[J]. ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 1996, 52 : C205 - C205
[5] STRUCTURE-BASED DESIGN OF CALCINEURIN INHIBITORS.
Kissinger, Charles R.
Parge, Hans
Knighton, Daniel
Pelletier, Laura
Tempczyk, Anna
Tatlock, John
Villafranca, Ernest
[J]. ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 1996, 52 : C201 - C201
[6] Structure-based design of ricin inhibitors.
Kerwin, SM
Ravikumar, KS
Miller, D
Robertus, J
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 219 : U54 - U54
[7] Structure-based design of novel conformationally restricted HIV protease inhibitors.
Rao, BG
Baker, CT
Court, JT
Deininger, DD
Kim, EE
Li, B
Novak, PM
Salituro, FG
Pazhanisamy, S
Schairer, WC
Tung, RD
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1997, 214 : 51 - COMP
[8] Crystals of the urokinase type plasminogen activator variant βc-uPA in complex with small molecule inhibitors open the way towards structure-based drug design
Zeslawska, E
Schweinitz, A
Karcher, A
Sondermann, P
Sperl, S
Stürzebecher, J
Jacob, U
[J]. JOURNAL OF MOLECULAR BIOLOGY, 2000, 301 (02) : 465 - 475
[9] Structure-based design of novel, urea-containing FKBP 12 inhibitors.
Dragovich, PS
Barker, JE
French, J
Imbacuan, M
Kalish, VJ
Kissinger, CR
Knighton, DR
Lewis, CT
Moomaw, EW
Parge, HE
Pelletier, LAK
Prins, TJ
Showalter, RE
Tatlock, JH
Tucker, KD
Villafranca, JE
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1996, 211 : 206 - MEDI
[10] In silico drug design and molecular docking of novel amidophosphonates and sulfamidophosphonates as inhibitors of urokinase-type plasminogen activator
Djouad, Seif-Eddine
Berredjem, Malika
Aoul, Fatima Zohra Hadjadj
Bouchareb, Fouzia
Guerfi, Meriem
Ben Hadda, Taibi
Aissaoui, Mohamed
Belhani, Billel
[J]. JOURNAL OF THE INDIAN CHEMICAL SOCIETY, 2022, 99 (09)

← 1 2 3 4 5 →